Seikagaku Reports FY 2Q18 Revenue of ¥7,030, -12% vs. FY 2Q17

By Mike Evers

Seikagaku continues slide caused by drug price reductions, posts FY 2Q18 revenue of ¥7,030 (USD $66MM), -12% vs. FY 2Q17.

Member-Only Content

SUBSCRIBE Login

Product Labels: Viscosupplement

Tags: Revenue Report